Correlation Analysis of PTPN22 Gene Polymorphism, Th17 / Treg Cells and Their Cytokines in GD with Different Iodine Nutritional Status

Hou Zhenjiang; Mu Zhaoxin; Wang Cuicui; Feng Jing; Chen Yunxia; Ma Jinqun; Liu Chunyan

doi:doi:10.11648/j.sjph.20210903.13

| Peer-Reviewed

Correlation Analysis of PTPN22 Gene Polymorphism, Th17 / Treg Cells and Their Cytokines in GD with Different Iodine Nutritional Status

Hou Zhenjiang, Mu Zhaoxin, Wang Cuicui, Feng Jing, Chen Yunxia, Ma Jinqun, Liu Chunyan

Published in Science Journal of Public Health (Volume 9, Issue 3)

Received: 6 April 2021 Accepted: Published: 24 May 2021

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Background: PTPN22 is an important candidate gene for autoimmune diseases and its SNP is involved in the pathogenesis of a variety of autoimmune diseases. Objective: To investigate the relationship between the PTPN22 gene polymorphism (rs2488457) and the Th17 and Treg cells and factors in the peripheral blood mononuclear cells (PBMC) of Graves' disease (GD) patients with different iodine nutrition conditions. Methods: We selected 100 GD patients and 60 healthy people in Cangzhou Central Hospital and People's Hospital from September 2019 to August 2020 and used SASP-PCR technology to calculate the PTPN22-1123 genotype and allele frequency. Flow cytometrywere used to detect the ratio and ratio of Th17 and Treg cells in PBMC and real-time PCR were used to detect the mRNA expression levels of ROR-γt and Foxp3. ELISA method was used to detect serum IL-17 and TGF-β levels. Results: The PTPN22 gene -1123G>C (rs2488457) of GD patients has a certain correlation with Th17 and Treg cells and their factors in PBMC. The distribution frequencies of various genotypes and alleles were statistically different between GD patients and the control group (P<0.05), but they had nothing to do with iodine nutrition status. The C/G and C/C genotypes at the PTPN22 gene (1123 G>C) of may increase the risk of GD, while the G/G genotype may reduce the risk of GD. Conclusion: PTPN22 gene polymorphism (rs2488457) in GD patients and Th17 and Treg cells and their factors in PBMC are related to GD susceptibility.

Published in	Science Journal of Public Health (Volume 9, Issue 3)
DOI	10.11648/j.sjph.20210903.13
Page(s)	83-91
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

PTPN22, Gene Polymorphism, Th17/Treg Cells and Factors, Iodine Nutritional Status, Graves' Disease

References

[1]	Chen X, Mei Y, He B, et al. General and specific genetic polymorphism of cytokines-related gene in AITD [J]. MediatorsInflamm, 2017, 2017 (1): 3916395.
[2]	Xue L, Pan C, Gu Z, et al. Genetic heterogeneity of susceptibility gene in different ethnic popu-lations: refining association study of PTPN22 for Graves'disease in a Chinese Han population [J]. PLoS One. 2013, 8 (12): e84514.
[3]	Su JP, Su SO, Zhang B, et al. The effects of different a mounts of iodine in take on the immunestatus of patients with Graves disease [J]. Clin Med China, 2012, 28 (1): 44-46.
[4]	Hou ZJ, Mu ZX, Wang CC. Research Progress of Th17/Treg Cells and Their Transcription Factors in Autoimmune Diseases [J]. American Journal of Clinical and Experimental Medicine 2019, 7 (4): 83-92.
[5]	Tang QL, Xue YM. Hashimoto's thyroiditis related gene research progress [J]. Drug Research, 2013, 10 (15): 42-46.
[6]	Chen MH, Dai B. Relationship between protein tyrosine phosphatase nonreceptor type 22 and rheumatoid arthritis [J]. Foreign Medicals Ciences Ectionof Medgeography, 2014, 35 (3): 252-255.
[7]	Li Sheng Dong. Analysis of association between PTPN22 and transcription factor FOXP3 gene polymorphisms and genetic susceptibility to systemic lupus erythematosus [J]. Chin Mode Doct, 2017, 55 (5): 1-4.
[8]	Su Y. Association Study between PTPN22 Gene Polymorphism and Myasthenia Gravis [D]. Master's thesis of shandong university, 2019.
[9]	Xu QH, Wu J, Chen ZT. Advances in the Research of the SPNs of PTPN22 Gene and Autoimm-UneRelated Diseaes [J]. Med J Wuhan Unive, 2017, 38 (5): 844-849.
[10]	Chinese Medical Association Endocrine Credits “China thyroid disease treatment guidelines” Writing Group. Chinese Guidelines for the Diagnosis and Treatment of thyroid diseases-Hyperthy-roidism [J]. Chin J Intern Med, 2007, 46 (10): 876-882.
[11]	Chinese Medical Association Endocrine Credits “China thyroid disease treatment guidelines” Writing Group. China thyroid disease treatment guidelines-iodine defi ciency disorders [J]. Chin J Intern Med, 2008, 47 (8): 689-690.
[12]	Chen Xiaoheng, Mei Yizhou, He Bei, et al. General and Specific Genetic Polymorphism of Cyto-kines-Related Gene in AITD Mediators Inflamm. 2017, 2017: 3916395.
[13]	Wang L, Wang B, Chen SR, et al. Effect of Selenium Supplementation on Recurrent Hyperthyroidism Caused by Graves' Disease: A Prospective Pilot Study [J]. Horm Metab Res, 2016, 48 (9): 559-564.
[14]	Li HX, Xiang N, Hu WK, et al. Relation between therapy options for Graves' disease and the course of Graves' ophthalmopathy: a systematic review and meta-analysis [J]. J Endocrinol Invest, 2016, 39 (11): 1225-1233.
[15]	Liu R. Twenty-eight year analysis of diffuse toxic GOITER, Hashimoto's thyroiditis, and pathological study of Vegf, tgf, CD20, CD45RO expression in diffuse toxic goiter, Hashimoto's thyroiditis [D]. Tianjin Medical University, Master's thesis, 2007.
[16]	Muhali FS, Song RH, Wang X, et a1. Genetic variants of BANK1 gene in autoimmune thyroid diseases: a case-control association study [J]. Exp Clin Endoerinol Diabetes, 2013, 121 (9): 556-560.
[17]	Teng XL, Zhang XM. Advances in Single-nucleotide polymer-phism and autoimmune thyroid disease [J]. J Bengbu Med Coll, 2013, 38 (11): 1519-1522.
[18]	Zhang YD, Tan LN, Wei HY, et al. Meta-analysis of CTLA-4 promoter-49 A/Gpolymorphism and Graves’disease in China [J]. Chin J Endocr Surg, 2013, 7 (1): 64-68.
[19]	Wang SQ, Yao YL. Research progress on toxic diffuse goiter and PTPN-22 gene polymorphism [J]. Front Med, 2016, 6 (3): 8-10.
[20]	Zeng QJ, Chen HY, Su JP. Src family kinases affect the expression of Nav1.1 in spiral ganglion neurons [J]. J Clin Otorhinolaryngol Head Neck Surg (China), 2014, 28 (11): 789-792.
[21]	Chen XH, Mei YZ, He B, et al. General and Specific Genetic Polymorphism of Cytokines-Related Gene in AITD [J]. Mediators Inflamm. 2017, 2017 (1): 3916395.
[22]	Kleinewietfeld M, Hafler DA. The plasticity of human Treg and Th17 cells and its role in autoimmunity [J]. Semin Immunol. 2013, 25 (4): 305-312.
[23]	Lempainen J, Laine AP, Hammais A, et al. Non-HLA gene effectson the disease process of type 1 diabetes: From HLA susceptibilityto overt disease [J]. J Autoimmun, 2015, 61: 45-53.
[24]	Wang L, Zhang L, Xiao H, et al. Interference of protein tyrosine phosphatase non-receptor type 22 inhibits NLRP3 inflammasome activation to alleviate inflammation after cerebral hemorrhage in rats [J]. J Third Milit Med Univ, 2019, 41 (24): 2409-2416.
[25]	Smyth D, Cooper JD, Collins JE, et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus [J]. Diabetes.2004, 53 (11): 3020-3023.
[26]	Vang T, Congia M, Macis MD, et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant [J]. Nat Genet.2005, 37 (12): 1317-1319.
[27]	Lee YH, Rho YH, Choi SJ, et a1. The PTPN22 C1858T functional polymorphism andautoimmune diseases--a meta-analysis Rheumatol, 2007, 46 (1): 49-56.
[28]	Chabchoub G, Teixiera EP, Maalej A, et al. The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population [J]. Ann Hum Biol, 2009; 36 (3): 342-349.
[29]	Ban Y, Tozaki T, Taniyama M, et al. Association of the protein tyrosine phosphatasenonreceptor 22 haplotypes with autoimmune thyroid disease in the Japanese population [J]. Thyroid, 2010, 20 (8): 893-899. Thyroid.2010, 20 (8): 893-899.
[30]	Song HD. Recent progress in identificafion of candidate genes of Graves’ disease [J]. Clin J Endocrinol Metab, 2011, 27 (12): 961-966.
[31]	Velaga MR, Wilson V, Jennings CE, et al. The codon 620 tryptophan allele of the lymphoidtyrosine phosphatase (LYP) gene is a major determinant of Graves' disease [J]. J Clin Endocrinol Metab. 2004, 89 (11): 5862-5865.
[32]	Criswell LA, Pfeiffer KA, Lum RF, et al. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes [J] Am J Hum Genet. 2005, 76 (4): 561-571.
[33]	Chabchoub G, Maalej A, Petit-Teixeira E et al. Polymorphisms in the protein tyrosine phosphatase (PTPN22) gene is not associated with autoimmune thyroid in a large affected Tunisian family [J]. Clin Immunol.2006, 120 (2): 235-236.
[34]	Skórka A, Bednarczuk T, Bar-Andziak E, et al. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correla-tion with age of onset [J]. Clin Endocrinol (Oxf).2005, 62 (6): 679-682.
[35]	Heward JM, Brand OJ, Barrett JC, et al. Association of PTPN22 haplotypes with Graves' disease [J]. J Clin Endocrinol Metab. 2007, 92 (2): 685-690.
[36]	Ichimura M, Kaku H, Fukutani T, et al. Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population [J]. Thyroid. 2008, 18 (6): 625-630.
[37]	Zhebrun D, Kudryashova Y, Babenko A, et al. Association of PTPN22 1858T/T genotype with type 1 diabetes, Graves' disease but not with rheumatoid arthritis in Russian population [J]. Aging (Albany NY).2011, 3 (4): 368-673.
[38]	Luo L, Cai B, Liu F, et al. Association of protein tyrosine phosphatase nonreceptor 22 (PTPN22) C1858T gene polymorphism with susceptibility to autoimmune thyroid diseases: a metaanalysis [J]. Endocr J, 2012, 59 (5): 439-445.
[39]	López-Cano DJ, Cadena-Sandoval D, Beltrán-Ramírez O, et al. The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves' disease in a Mexican population [J]. Inflamm Res. 2017, 66 (9): 775-781.
[40]	Shehjar F, Dil-Afroze, Misgar, Riaz A, et al. PTPN22 1858 C/T Exon Polymorphism is not Associated with Graves' Disease in Kashmiri population [J]. Indian J Endocrinol Metab.2018, 22 (4): 457-460.
[41]	Wawrusiewicz-Kurylonek N, Koper-Lenkiewicz OM, Gościk J, et al. Association of PTPN22 polymorphism and its correlation with Graves' disease susceptibility in Polish adult population-A preliminary study [J]. Mol Genet Genomic Med. 2019, 7 (6): e661.
[42]	Bufalo NE, Dos Santos EB, Rocha AG, et al. Polymorphisms of the genes CTLA4, PTPN22, CD40, and PPARG and their roles in Graves' disease: susceptibility and clinical features [J]. Endocrine. 2021, 71 (1): 104-112.
[43]	Zhang ZH, Zhang XL, Chen F, et al. Genetic polymorphism of rheumatoid arthritis related gene PTPN22 C1858T in 6 ethnic groups in China [J]. Inter J Genetics, 2007, 30 (2): 81-84.
[44]	Zhang ZH, Chen F, Zhang XL, et al. PTPN22 allele polym orphism s in 15 Chinese populations [J]. Int J Immunogenet, 2008, 35 (6): 433-437.
[45]	Wang S, Zhao ZF, Jiang XH, et al. Relationship between LYP /PTPN22 and Graves’ disease in Han nationality from Shanghai Of China [J]. J Shanghai Jiaotong Univ (Medical Science), 2007, 27 (8): 984-986.
[46]	Ye Juan, Ren An. Relationship between PTPN22 gene polymorphism andGraves' diseasein Han nationality from Anhui province [J]. China Journal of Modern Medicine, 2015, 25 (7): 44-46.
[47]	Zheng RZ, Zhang SH, Li R, et al. Study on the relationship between polymorphism of PTPN22 and Graves ’disease of Han nationality in Chongqing area [J]. J Chongqing Med Univ, 2008, 33 (1): 22-24.
[48]	Yu ZY, Zhang JA, Maier-haba, et al. Association of polymorphism of protein tyrosine phosphatasenonreceptor-22 gene with AITD [J]. Chin J Cell Mol Immuno, 2008, 24 (8): 804-807.
[49]	Tizaoui K, Kim SH, Jeong GH, et al. Association of PTPN22 1858C/T Polymorphism with Autoimmune Diseases: A Systematic Review and Bayesian Approach [J]. J Clin Med, 2019, 8 (3), 347 (1-22).
[50]	Ban Y, Tozaki T, Taniyama M, et al. The codon 620 single nucleotide polymorphism of the protein tyrosine phosphatase- 22 gene does not contribute to autoimmune thyroid disease suscep-tibility in theJapanese [J]. Thyroid, 2005, 15 (10): 1115-1118.
[51]	Jing Feng, Cuicui Wang, Zhenjiang Hou, et al. Correlation Analysis of Thyroid Function and Autoantibodies in Graves’ Disease Patients with different Iodine nutritional Status [J]. Science J Public Health, 2020, 8 (6): 168-176.
[52]	Jing Feng, Cuicui Wang, Zhaoxin Mu, et al. Research on the Role of Th17Treg Cells and their Factors in Graves' Disease with different Iodine Nutritional Status [J]. Science J Public Health, 2021, 9 (1): 1-11.

Cite This Article

Plain Text BibTeX RIS

APA Style

Hou Zhenjiang, Mu Zhaoxin, Wang Cuicui, Feng Jing, Chen Yunxia, et al. (2021). Correlation Analysis of PTPN22 Gene Polymorphism, Th17 / Treg Cells and Their Cytokines in GD with Different Iodine Nutritional Status. Science Journal of Public Health, 9(3), 83-91. https://doi.org/10.11648/j.sjph.20210903.13

Copy | Download

ACS Style

Hou Zhenjiang; Mu Zhaoxin; Wang Cuicui; Feng Jing; Chen Yunxia, et al. Correlation Analysis of PTPN22 Gene Polymorphism, Th17 / Treg Cells and Their Cytokines in GD with Different Iodine Nutritional Status. Sci. J. Public Health 2021, 9(3), 83-91. doi: 10.11648/j.sjph.20210903.13

Copy | Download

AMA Style

Hou Zhenjiang, Mu Zhaoxin, Wang Cuicui, Feng Jing, Chen Yunxia, et al. Correlation Analysis of PTPN22 Gene Polymorphism, Th17 / Treg Cells and Their Cytokines in GD with Different Iodine Nutritional Status. Sci J Public Health. 2021;9(3):83-91. doi: 10.11648/j.sjph.20210903.13

Copy | Download

@article{10.11648/j.sjph.20210903.13,
  author = {Hou Zhenjiang and Mu Zhaoxin and Wang Cuicui and Feng Jing and Chen Yunxia and Ma Jinqun and Liu Chunyan},
  title = {Correlation Analysis of PTPN22 Gene Polymorphism, Th17 / Treg Cells and Their Cytokines in GD with Different Iodine Nutritional Status},
  journal = {Science Journal of Public Health},
  volume = {9},
  number = {3},
  pages = {83-91},
  doi = {10.11648/j.sjph.20210903.13},
  url = {https://doi.org/10.11648/j.sjph.20210903.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sjph.20210903.13},
  abstract = {Background: PTPN22 is an important candidate gene for autoimmune diseases and its SNP is involved in the pathogenesis of a variety of autoimmune diseases. Objective: To investigate the relationship between the PTPN22 gene polymorphism (rs2488457) and the Th17 and Treg cells and factors in the peripheral blood mononuclear cells (PBMC) of Graves' disease (GD) patients with different iodine nutrition conditions. Methods: We selected 100 GD patients and 60 healthy people in Cangzhou Central Hospital and People's Hospital from September 2019 to August 2020 and used SASP-PCR technology to calculate the PTPN22-1123 genotype and allele frequency. Flow cytometrywere used to detect the ratio and ratio of Th17 and Treg cells in PBMC and real-time PCR were used to detect the mRNA expression levels of ROR-γt and Foxp3. ELISA method was used to detect serum IL-17 and TGF-β levels. Results: The PTPN22 gene -1123G>C (rs2488457) of GD patients has a certain correlation with Th17 and Treg cells and their factors in PBMC. The distribution frequencies of various genotypes and alleles were statistically different between GD patients and the control group (PC) of may increase the risk of GD, while the G/G genotype may reduce the risk of GD. Conclusion: PTPN22 gene polymorphism (rs2488457) in GD patients and Th17 and Treg cells and their factors in PBMC are related to GD susceptibility.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Correlation Analysis of PTPN22 Gene Polymorphism, Th17 / Treg Cells and Their Cytokines in GD with Different Iodine Nutritional Status
AU  - Hou Zhenjiang
AU  - Mu Zhaoxin
AU  - Wang Cuicui
AU  - Feng Jing
AU  - Chen Yunxia
AU  - Ma Jinqun
AU  - Liu Chunyan
Y1  - 2021/05/24
PY  - 2021
N1  - https://doi.org/10.11648/j.sjph.20210903.13
DO  - 10.11648/j.sjph.20210903.13
T2  - Science Journal of Public Health
JF  - Science Journal of Public Health
JO  - Science Journal of Public Health
SP  - 83
EP  - 91
PB  - Science Publishing Group
SN  - 2328-7950
UR  - https://doi.org/10.11648/j.sjph.20210903.13
AB  - Background: PTPN22 is an important candidate gene for autoimmune diseases and its SNP is involved in the pathogenesis of a variety of autoimmune diseases. Objective: To investigate the relationship between the PTPN22 gene polymorphism (rs2488457) and the Th17 and Treg cells and factors in the peripheral blood mononuclear cells (PBMC) of Graves' disease (GD) patients with different iodine nutrition conditions. Methods: We selected 100 GD patients and 60 healthy people in Cangzhou Central Hospital and People's Hospital from September 2019 to August 2020 and used SASP-PCR technology to calculate the PTPN22-1123 genotype and allele frequency. Flow cytometrywere used to detect the ratio and ratio of Th17 and Treg cells in PBMC and real-time PCR were used to detect the mRNA expression levels of ROR-γt and Foxp3. ELISA method was used to detect serum IL-17 and TGF-β levels. Results: The PTPN22 gene -1123G>C (rs2488457) of GD patients has a certain correlation with Th17 and Treg cells and their factors in PBMC. The distribution frequencies of various genotypes and alleles were statistically different between GD patients and the control group (PC) of may increase the risk of GD, while the G/G genotype may reduce the risk of GD. Conclusion: PTPN22 gene polymorphism (rs2488457) in GD patients and Th17 and Treg cells and their factors in PBMC are related to GD susceptibility.
VL  - 9
IS  - 3
ER  -

Copy | Download

Author Information

Hou Zhenjiang

Cangzhou Thyroid Disease Engineering Technology Research Center, Cangzhou Medical College, Cangzhou, China
Mu Zhaoxin

Cangzhou Thyroid Disease Engineering Technology Research Center, Cangzhou Medical College, Cangzhou, China
Wang Cuicui

Department of Medical Technology, Cangzhou Medical College, Cangzhou, China
Feng Jing

Cangzhou Central Hospital, Cangzhou, China
Chen Yunxia

Endocrinology Department, Cangzhou People's Hospital, Cangzhou, China
Ma Jinqun

Endocrinology Department, Cangzhou People's Hospital, Cangzhou, China
Liu Chunyan

Endocrinology Department, Cangzhou People's Hospital, Cangzhou, China

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Hou Zhenjiang, Mu Zhaoxin, Wang Cuicui, Feng Jing, Chen Yunxia, et al. (2021). Correlation Analysis of PTPN22 Gene Polymorphism, Th17 / Treg Cells and Their Cytokines in GD with Different Iodine Nutritional Status. Science Journal of Public Health, 9(3), 83-91. https://doi.org/10.11648/j.sjph.20210903.13

Copy | Download

ACS Style

Hou Zhenjiang; Mu Zhaoxin; Wang Cuicui; Feng Jing; Chen Yunxia, et al. Correlation Analysis of PTPN22 Gene Polymorphism, Th17 / Treg Cells and Their Cytokines in GD with Different Iodine Nutritional Status. Sci. J. Public Health 2021, 9(3), 83-91. doi: 10.11648/j.sjph.20210903.13

Copy | Download

AMA Style

Hou Zhenjiang, Mu Zhaoxin, Wang Cuicui, Feng Jing, Chen Yunxia, et al. Correlation Analysis of PTPN22 Gene Polymorphism, Th17 / Treg Cells and Their Cytokines in GD with Different Iodine Nutritional Status. Sci J Public Health. 2021;9(3):83-91. doi: 10.11648/j.sjph.20210903.13

Copy | Download

@article{10.11648/j.sjph.20210903.13,
  author = {Hou Zhenjiang and Mu Zhaoxin and Wang Cuicui and Feng Jing and Chen Yunxia and Ma Jinqun and Liu Chunyan},
  title = {Correlation Analysis of PTPN22 Gene Polymorphism, Th17 / Treg Cells and Their Cytokines in GD with Different Iodine Nutritional Status},
  journal = {Science Journal of Public Health},
  volume = {9},
  number = {3},
  pages = {83-91},
  doi = {10.11648/j.sjph.20210903.13},
  url = {https://doi.org/10.11648/j.sjph.20210903.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sjph.20210903.13},
  abstract = {Background: PTPN22 is an important candidate gene for autoimmune diseases and its SNP is involved in the pathogenesis of a variety of autoimmune diseases. Objective: To investigate the relationship between the PTPN22 gene polymorphism (rs2488457) and the Th17 and Treg cells and factors in the peripheral blood mononuclear cells (PBMC) of Graves' disease (GD) patients with different iodine nutrition conditions. Methods: We selected 100 GD patients and 60 healthy people in Cangzhou Central Hospital and People's Hospital from September 2019 to August 2020 and used SASP-PCR technology to calculate the PTPN22-1123 genotype and allele frequency. Flow cytometrywere used to detect the ratio and ratio of Th17 and Treg cells in PBMC and real-time PCR were used to detect the mRNA expression levels of ROR-γt and Foxp3. ELISA method was used to detect serum IL-17 and TGF-β levels. Results: The PTPN22 gene -1123G>C (rs2488457) of GD patients has a certain correlation with Th17 and Treg cells and their factors in PBMC. The distribution frequencies of various genotypes and alleles were statistically different between GD patients and the control group (PC) of may increase the risk of GD, while the G/G genotype may reduce the risk of GD. Conclusion: PTPN22 gene polymorphism (rs2488457) in GD patients and Th17 and Treg cells and their factors in PBMC are related to GD susceptibility.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Correlation Analysis of PTPN22 Gene Polymorphism, Th17 / Treg Cells and Their Cytokines in GD with Different Iodine Nutritional Status
AU  - Hou Zhenjiang
AU  - Mu Zhaoxin
AU  - Wang Cuicui
AU  - Feng Jing
AU  - Chen Yunxia
AU  - Ma Jinqun
AU  - Liu Chunyan
Y1  - 2021/05/24
PY  - 2021
N1  - https://doi.org/10.11648/j.sjph.20210903.13
DO  - 10.11648/j.sjph.20210903.13
T2  - Science Journal of Public Health
JF  - Science Journal of Public Health
JO  - Science Journal of Public Health
SP  - 83
EP  - 91
PB  - Science Publishing Group
SN  - 2328-7950
UR  - https://doi.org/10.11648/j.sjph.20210903.13
AB  - Background: PTPN22 is an important candidate gene for autoimmune diseases and its SNP is involved in the pathogenesis of a variety of autoimmune diseases. Objective: To investigate the relationship between the PTPN22 gene polymorphism (rs2488457) and the Th17 and Treg cells and factors in the peripheral blood mononuclear cells (PBMC) of Graves' disease (GD) patients with different iodine nutrition conditions. Methods: We selected 100 GD patients and 60 healthy people in Cangzhou Central Hospital and People's Hospital from September 2019 to August 2020 and used SASP-PCR technology to calculate the PTPN22-1123 genotype and allele frequency. Flow cytometrywere used to detect the ratio and ratio of Th17 and Treg cells in PBMC and real-time PCR were used to detect the mRNA expression levels of ROR-γt and Foxp3. ELISA method was used to detect serum IL-17 and TGF-β levels. Results: The PTPN22 gene -1123G>C (rs2488457) of GD patients has a certain correlation with Th17 and Treg cells and their factors in PBMC. The distribution frequencies of various genotypes and alleles were statistically different between GD patients and the control group (PC) of may increase the risk of GD, while the G/G genotype may reduce the risk of GD. Conclusion: PTPN22 gene polymorphism (rs2488457) in GD patients and Th17 and Treg cells and their factors in PBMC are related to GD susceptibility.
VL  - 9
IS  - 3
ER  -

Copy | Download